Sentry’s Head of Industry Relations authors new 340B compliance whitepaper
Lisa Scholz, PharmD, MBA, FACHE, has authored a new whitepaper for the Texas Healthcare Trustees outlining the three key compliance factors 340B covered entities must contend with and discussing the unique operational challenges they pose for modern hospitals.
Titled “Key compliance factors of the 340B program and the challenges they pose for hospitals,” the whitepaper details the three basic pillars of 340B compliance:
- 11-digit National Drug Code (NDC) matching
- Policies & Procedures
Scholz outlines the challenges 340B compliance presents for modern hospital information systems, workflows and operations. She also offers key questions to ask and best practices to covered entities that need help strengthening their compliance oversight or hospitals that are considering participating in 340B.
Fill out the form below to download the full whitepaper.